Oak Ridge Investments’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Oak Ridge Investments’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,326	Closed	-$469K	–	167
2022 Q1	$469K	Sell	40,326 -19,426	-33%	-$231K	0.05%	146
2021 Q4	$1.09M	Sell	59,752 -4,590	-7%	-$58.2K	0.09%	132
2021 Q3	$763K	Sell	64,342 -1,756	-3%	-$25.6K	0.07%	148
2021 Q2	$1.14M	Sell	66,098 -7,263	-10%	-$138K	0.1%	136
2021 Q1	$1.34M	Buy	73,361 +1,496	+2%	+$31.4K	0.12%	119
2020 Q4	$1.35M	Sell	71,865 -18,126	-20%	-$391K	0.12%	128
2020 Q3	$1.9M	Sell	89,991 -7,435	-8%	-$174K	0.15%	116
2020 Q2	$2.81M	Buy	+97,426	New	+$2.94M	0.24%	108

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Oak Ridge Investments's OYST Position: Q2 2022 in Review

Oak Ridge Investments sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 40,326 shares — an estimated $469K sold.

Oak Ridge Investments first reported a position in OYST in Q2 2020 and held it in 8 quarters. The position peaked at $2.81M in Q2 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

Oak Ridge Investments reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Oak Ridge Investments sold 40,326 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $469K.
Oak Ridge Investments first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Oak Ridge Investments's Oyster Point Pharma, Inc. Common Stock position peaked at $2.81M in Q2 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Oak Ridge Investments's 13F filing for Q2 2022, filed 28 Jul 2022.